In particular, the expression of neuropilin-1, VEGF, and VEGFR2 in tumor cells remained unchanged (unchanged auto- and paracrine VEGF tumor cell signaling), independently of the therapeutic modality (at least under the conditions applied in this study). The gene discussed is NRP1; the disease is neoplasm.